ACTIVE

GYNEZOL

Financial year 2025 · Closed on 31/12/2025

Gross margin57,8 k €+55,1 %over 1 year
Equity5,5 k €0,0 %over 1 year

Identity

Source · BCE/KBO

GYNEZOL is a Private limited company incorporated in 2024. Its main activity is: Specialist medical practice activities. Its registered office is in Genk.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 1008.674.987
Incorporation
23/04/2024
Legal form
Private limited company
Registered office
Synaps Park 1
3600 Genk · FlandreSee on map
Contributed capital
5 500,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 33004
Signals
ProfitableGood liquidityPositive EBITDAHealthy social debts

Financials

Source · NBB, 2 filings

Trend over 2 financial years

20252024
Income statement
Gross margin57,8 k €37,3 k €
EBITDA4,9 k €3 k €
Operating result1,2 k €612,9 €
Balance sheet
Equity5,5 k €5,5 k €
Total assets2,9 M €2,3 M €
Cash85,9 k €45,7 k €
Debts87 k €187 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 1 ended

Active mandates

Eva De Cuyper

Director · since 23 avril 2024

Active
Jean-Christophe Schobbens

Director · since 23 avril 2024

Active
Julie Marie Peter Faes

Director · since 23 avril 2024

Active

Ended mandates

Julie Faes

Director · since 23 avril 2024

Ended

Other companies at this address

Synaps Park 1 3600 Genk
CompanyCBE no.
1034.852.913
0728.689.239
1028.589.780
1017.291.656
0671.771.718
0730.889.357
0507.746.696
0661.685.696
GyneHoeselt● Active
0771.681.025
HLG● Active
0697.858.283
0760.436.151
0723.574.072
Neurho● Active
0753.709.497
0461.734.252
0256.543.917
ZOLBIZZ● Active
0707.905.406

Full financial information

Source · NBB
20252024
Type of accountAbridged modelAbridged model
Start of the financial year01/01/202501/01/2024
Closing of the financial year31/12/202531/12/2024
Length of the financial year12 months12 months
Filing date31/08/202615/07/2025
General meeting30/06/202627/06/2025
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 2 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202530/06/202631/08/2026DutchPDF
Abridged model31/12/202427/06/202515/07/2025DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 1 ended

Active mandates

Eva De Cuyper

Director · since 23 avril 2024

Active
Jean-Christophe Schobbens

Director · since 23 avril 2024

Active
Julie Marie Peter Faes

Director · since 23 avril 2024

Active

Ended mandates

Julie Faes

Director · since 23 avril 2024

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other25/04/2024
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025
  2. 2024
    Annual accounts 2024
  3. 23/04/2024
    IncorporationPrivate limited company